ANNALS OF HEMATOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=800300, encodeId=0bef80030014, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：大概4个月就接受了小修了1次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MX6tU5ibUmUNUc3QuraXVibmr9eSic7DuT3y7gKap2C8NQl1DicYOy0tgTHxNNZbNHfXwyvhWdt2CUhiaicYHHEggDUg/132, createdBy=2ede2416652, createdName=Cynthia开心, createdTime=Mon Jun 29 18:43:35 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574755, encodeId=e42c5e47558e, content=三个月了，一审还在under review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eunqL11r55A8WAWlyWs0EnafPqUs8awD2Jsk71ggkmlWicOGpfTScjbNxecDibU9J2TQjcVafFgY0hju6sfJS9rQ/132, createdBy=c6852367423, createdName=122e6881m72暂无昵称, createdTime=Tue Aug 13 21:09:00 CST 2019, time=2019-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170187, encodeId=a58f21e0187a5, content=作者登录页面是换吗，怎么点击submit 后，变成需要重新注册了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f108140910, createdName=ms5000001791427926, createdTime=Wed Nov 22 10:32:05 CST 2023, time=2023-11-22, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2157610, encodeId=45f2215e610ff, content=审稿速度:1.0 偏重的研究方向：hematology 经验分享：under review 状态一般持续多久呀？临床型的文章更容易中吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Thu Sep 14 00:23:58 CST 2023, time=2023-09-14, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=977647, encodeId=287b9e7647f7, content=请问接受个案吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ca9f5408920, createdName=ms1000000940702777, createdTime=Mon Jun 28 17:54:44 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975847, encodeId=08639e58478e, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：血液病 经验分享：一个月给了意见，给了3个月，修回接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a1f5188251, createdName=1470fb34m70(暂无昵称), createdTime=Tue Jun 22 16:57:26 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187968, encodeId=7c5b118e9686f, content=偏重的研究方向：白血病 经验分享：2022年1月23投，现在还是submit to Journal，求问这个状态啥时候才会提交给编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd785646397, createdName=ms4000000531946229, createdTime=Tue Jan 25 10:50:34 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086716, encodeId=a6d51086e16f6, content=每个期刊梯度一般情况下选择几个备选期刊合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086715, encodeId=8d891086e153e, content=选刊时需要从高到低设置期刊梯度吗？一般设置几个梯度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580213, encodeId=d0d9580213e2, content=啊，难道4个月了，还没送外审蛐蛐2 2019-11-20 00:00:00 发表: under review, beContent=蛐蛐2 2019-11-20 00:00:00 发表: under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/07/daf9b2a0c54c44f56adacf00fe8c4244.jpg, createdBy=356a5091985, createdName=13045d5bb3m, createdTime=Thu Nov 21 00:00:00 CST 2019, time=2019-11-21, status=1, ipAttribution=)]

2020-06-29 Cynthia开心

审稿速度:6.0 | 投稿命中率:50.0
经验分享：大概4个月就接受了小修了1次

262 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=800300, encodeId=0bef80030014, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：大概4个月就接受了小修了1次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MX6tU5ibUmUNUc3QuraXVibmr9eSic7DuT3y7gKap2C8NQl1DicYOy0tgTHxNNZbNHfXwyvhWdt2CUhiaicYHHEggDUg/132, createdBy=2ede2416652, createdName=Cynthia开心, createdTime=Mon Jun 29 18:43:35 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574755, encodeId=e42c5e47558e, content=三个月了，一审还在under review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eunqL11r55A8WAWlyWs0EnafPqUs8awD2Jsk71ggkmlWicOGpfTScjbNxecDibU9J2TQjcVafFgY0hju6sfJS9rQ/132, createdBy=c6852367423, createdName=122e6881m72暂无昵称, createdTime=Tue Aug 13 21:09:00 CST 2019, time=2019-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170187, encodeId=a58f21e0187a5, content=作者登录页面是换吗，怎么点击submit 后，变成需要重新注册了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f108140910, createdName=ms5000001791427926, createdTime=Wed Nov 22 10:32:05 CST 2023, time=2023-11-22, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2157610, encodeId=45f2215e610ff, content=审稿速度:1.0 偏重的研究方向：hematology 经验分享：under review 状态一般持续多久呀？临床型的文章更容易中吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Thu Sep 14 00:23:58 CST 2023, time=2023-09-14, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=977647, encodeId=287b9e7647f7, content=请问接受个案吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ca9f5408920, createdName=ms1000000940702777, createdTime=Mon Jun 28 17:54:44 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975847, encodeId=08639e58478e, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：血液病 经验分享：一个月给了意见，给了3个月，修回接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a1f5188251, createdName=1470fb34m70(暂无昵称), createdTime=Tue Jun 22 16:57:26 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187968, encodeId=7c5b118e9686f, content=偏重的研究方向：白血病 经验分享：2022年1月23投，现在还是submit to Journal，求问这个状态啥时候才会提交给编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd785646397, createdName=ms4000000531946229, createdTime=Tue Jan 25 10:50:34 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086716, encodeId=a6d51086e16f6, content=每个期刊梯度一般情况下选择几个备选期刊合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086715, encodeId=8d891086e153e, content=选刊时需要从高到低设置期刊梯度吗？一般设置几个梯度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580213, encodeId=d0d9580213e2, content=啊，难道4个月了，还没送外审蛐蛐2 2019-11-20 00:00:00 发表: under review, beContent=蛐蛐2 2019-11-20 00:00:00 发表: under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/07/daf9b2a0c54c44f56adacf00fe8c4244.jpg, createdBy=356a5091985, createdName=13045d5bb3m, createdTime=Thu Nov 21 00:00:00 CST 2019, time=2019-11-21, status=1, ipAttribution=)]

2019-08-13 122e6881m72暂无昵称

三个月了，一审还在under review。。。

115 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=800300, encodeId=0bef80030014, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：大概4个月就接受了小修了1次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MX6tU5ibUmUNUc3QuraXVibmr9eSic7DuT3y7gKap2C8NQl1DicYOy0tgTHxNNZbNHfXwyvhWdt2CUhiaicYHHEggDUg/132, createdBy=2ede2416652, createdName=Cynthia开心, createdTime=Mon Jun 29 18:43:35 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574755, encodeId=e42c5e47558e, content=三个月了，一审还在under review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eunqL11r55A8WAWlyWs0EnafPqUs8awD2Jsk71ggkmlWicOGpfTScjbNxecDibU9J2TQjcVafFgY0hju6sfJS9rQ/132, createdBy=c6852367423, createdName=122e6881m72暂无昵称, createdTime=Tue Aug 13 21:09:00 CST 2019, time=2019-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170187, encodeId=a58f21e0187a5, content=作者登录页面是换吗，怎么点击submit 后，变成需要重新注册了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f108140910, createdName=ms5000001791427926, createdTime=Wed Nov 22 10:32:05 CST 2023, time=2023-11-22, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2157610, encodeId=45f2215e610ff, content=审稿速度:1.0 偏重的研究方向：hematology 经验分享：under review 状态一般持续多久呀？临床型的文章更容易中吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Thu Sep 14 00:23:58 CST 2023, time=2023-09-14, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=977647, encodeId=287b9e7647f7, content=请问接受个案吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ca9f5408920, createdName=ms1000000940702777, createdTime=Mon Jun 28 17:54:44 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975847, encodeId=08639e58478e, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：血液病 经验分享：一个月给了意见，给了3个月，修回接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a1f5188251, createdName=1470fb34m70(暂无昵称), createdTime=Tue Jun 22 16:57:26 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187968, encodeId=7c5b118e9686f, content=偏重的研究方向：白血病 经验分享：2022年1月23投，现在还是submit to Journal，求问这个状态啥时候才会提交给编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd785646397, createdName=ms4000000531946229, createdTime=Tue Jan 25 10:50:34 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086716, encodeId=a6d51086e16f6, content=每个期刊梯度一般情况下选择几个备选期刊合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086715, encodeId=8d891086e153e, content=选刊时需要从高到低设置期刊梯度吗？一般设置几个梯度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580213, encodeId=d0d9580213e2, content=啊，难道4个月了，还没送外审蛐蛐2 2019-11-20 00:00:00 发表: under review, beContent=蛐蛐2 2019-11-20 00:00:00 发表: under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/07/daf9b2a0c54c44f56adacf00fe8c4244.jpg, createdBy=356a5091985, createdName=13045d5bb3m, createdTime=Thu Nov 21 00:00:00 CST 2019, time=2019-11-21, status=1, ipAttribution=)]

2023-11-22 ms5000001791427926 来自黑龙江省

作者登录页面是换吗，怎么点击submit 后，变成需要重新注册了呢？

27 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=800300, encodeId=0bef80030014, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：大概4个月就接受了小修了1次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MX6tU5ibUmUNUc3QuraXVibmr9eSic7DuT3y7gKap2C8NQl1DicYOy0tgTHxNNZbNHfXwyvhWdt2CUhiaicYHHEggDUg/132, createdBy=2ede2416652, createdName=Cynthia开心, createdTime=Mon Jun 29 18:43:35 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574755, encodeId=e42c5e47558e, content=三个月了，一审还在under review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eunqL11r55A8WAWlyWs0EnafPqUs8awD2Jsk71ggkmlWicOGpfTScjbNxecDibU9J2TQjcVafFgY0hju6sfJS9rQ/132, createdBy=c6852367423, createdName=122e6881m72暂无昵称, createdTime=Tue Aug 13 21:09:00 CST 2019, time=2019-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170187, encodeId=a58f21e0187a5, content=作者登录页面是换吗，怎么点击submit 后，变成需要重新注册了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f108140910, createdName=ms5000001791427926, createdTime=Wed Nov 22 10:32:05 CST 2023, time=2023-11-22, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2157610, encodeId=45f2215e610ff, content=审稿速度:1.0 偏重的研究方向：hematology 经验分享：under review 状态一般持续多久呀？临床型的文章更容易中吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Thu Sep 14 00:23:58 CST 2023, time=2023-09-14, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=977647, encodeId=287b9e7647f7, content=请问接受个案吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ca9f5408920, createdName=ms1000000940702777, createdTime=Mon Jun 28 17:54:44 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975847, encodeId=08639e58478e, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：血液病 经验分享：一个月给了意见，给了3个月，修回接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a1f5188251, createdName=1470fb34m70(暂无昵称), createdTime=Tue Jun 22 16:57:26 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187968, encodeId=7c5b118e9686f, content=偏重的研究方向：白血病 经验分享：2022年1月23投，现在还是submit to Journal，求问这个状态啥时候才会提交给编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd785646397, createdName=ms4000000531946229, createdTime=Tue Jan 25 10:50:34 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086716, encodeId=a6d51086e16f6, content=每个期刊梯度一般情况下选择几个备选期刊合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086715, encodeId=8d891086e153e, content=选刊时需要从高到低设置期刊梯度吗？一般设置几个梯度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580213, encodeId=d0d9580213e2, content=啊，难道4个月了，还没送外审蛐蛐2 2019-11-20 00:00:00 发表: under review, beContent=蛐蛐2 2019-11-20 00:00:00 发表: under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/07/daf9b2a0c54c44f56adacf00fe8c4244.jpg, createdBy=356a5091985, createdName=13045d5bb3m, createdTime=Thu Nov 21 00:00:00 CST 2019, time=2019-11-21, status=1, ipAttribution=)]

2023-09-14 清清欢来自江西省

审稿速度:1.0
偏重的研究方向：hematology
经验分享：under review 状态一般持续多久呀？临床型的文章更容易中吗？

60 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=800300, encodeId=0bef80030014, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：大概4个月就接受了小修了1次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MX6tU5ibUmUNUc3QuraXVibmr9eSic7DuT3y7gKap2C8NQl1DicYOy0tgTHxNNZbNHfXwyvhWdt2CUhiaicYHHEggDUg/132, createdBy=2ede2416652, createdName=Cynthia开心, createdTime=Mon Jun 29 18:43:35 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574755, encodeId=e42c5e47558e, content=三个月了，一审还在under review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eunqL11r55A8WAWlyWs0EnafPqUs8awD2Jsk71ggkmlWicOGpfTScjbNxecDibU9J2TQjcVafFgY0hju6sfJS9rQ/132, createdBy=c6852367423, createdName=122e6881m72暂无昵称, createdTime=Tue Aug 13 21:09:00 CST 2019, time=2019-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170187, encodeId=a58f21e0187a5, content=作者登录页面是换吗，怎么点击submit 后，变成需要重新注册了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f108140910, createdName=ms5000001791427926, createdTime=Wed Nov 22 10:32:05 CST 2023, time=2023-11-22, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2157610, encodeId=45f2215e610ff, content=审稿速度:1.0 偏重的研究方向：hematology 经验分享：under review 状态一般持续多久呀？临床型的文章更容易中吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Thu Sep 14 00:23:58 CST 2023, time=2023-09-14, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=977647, encodeId=287b9e7647f7, content=请问接受个案吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ca9f5408920, createdName=ms1000000940702777, createdTime=Mon Jun 28 17:54:44 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975847, encodeId=08639e58478e, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：血液病 经验分享：一个月给了意见，给了3个月，修回接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a1f5188251, createdName=1470fb34m70(暂无昵称), createdTime=Tue Jun 22 16:57:26 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187968, encodeId=7c5b118e9686f, content=偏重的研究方向：白血病 经验分享：2022年1月23投，现在还是submit to Journal，求问这个状态啥时候才会提交给编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd785646397, createdName=ms4000000531946229, createdTime=Tue Jan 25 10:50:34 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086716, encodeId=a6d51086e16f6, content=每个期刊梯度一般情况下选择几个备选期刊合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086715, encodeId=8d891086e153e, content=选刊时需要从高到低设置期刊梯度吗？一般设置几个梯度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580213, encodeId=d0d9580213e2, content=啊，难道4个月了，还没送外审蛐蛐2 2019-11-20 00:00:00 发表: under review, beContent=蛐蛐2 2019-11-20 00:00:00 发表: under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/07/daf9b2a0c54c44f56adacf00fe8c4244.jpg, createdBy=356a5091985, createdName=13045d5bb3m, createdTime=Thu Nov 21 00:00:00 CST 2019, time=2019-11-21, status=1, ipAttribution=)]

2021-06-28 ms1000000940702777

请问接受个案吗？

223 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=800300, encodeId=0bef80030014, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：大概4个月就接受了小修了1次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MX6tU5ibUmUNUc3QuraXVibmr9eSic7DuT3y7gKap2C8NQl1DicYOy0tgTHxNNZbNHfXwyvhWdt2CUhiaicYHHEggDUg/132, createdBy=2ede2416652, createdName=Cynthia开心, createdTime=Mon Jun 29 18:43:35 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574755, encodeId=e42c5e47558e, content=三个月了，一审还在under review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eunqL11r55A8WAWlyWs0EnafPqUs8awD2Jsk71ggkmlWicOGpfTScjbNxecDibU9J2TQjcVafFgY0hju6sfJS9rQ/132, createdBy=c6852367423, createdName=122e6881m72暂无昵称, createdTime=Tue Aug 13 21:09:00 CST 2019, time=2019-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170187, encodeId=a58f21e0187a5, content=作者登录页面是换吗，怎么点击submit 后，变成需要重新注册了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f108140910, createdName=ms5000001791427926, createdTime=Wed Nov 22 10:32:05 CST 2023, time=2023-11-22, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2157610, encodeId=45f2215e610ff, content=审稿速度:1.0 偏重的研究方向：hematology 经验分享：under review 状态一般持续多久呀？临床型的文章更容易中吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Thu Sep 14 00:23:58 CST 2023, time=2023-09-14, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=977647, encodeId=287b9e7647f7, content=请问接受个案吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ca9f5408920, createdName=ms1000000940702777, createdTime=Mon Jun 28 17:54:44 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975847, encodeId=08639e58478e, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：血液病 经验分享：一个月给了意见，给了3个月，修回接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a1f5188251, createdName=1470fb34m70(暂无昵称), createdTime=Tue Jun 22 16:57:26 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187968, encodeId=7c5b118e9686f, content=偏重的研究方向：白血病 经验分享：2022年1月23投，现在还是submit to Journal，求问这个状态啥时候才会提交给编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd785646397, createdName=ms4000000531946229, createdTime=Tue Jan 25 10:50:34 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086716, encodeId=a6d51086e16f6, content=每个期刊梯度一般情况下选择几个备选期刊合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086715, encodeId=8d891086e153e, content=选刊时需要从高到低设置期刊梯度吗？一般设置几个梯度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580213, encodeId=d0d9580213e2, content=啊，难道4个月了，还没送外审蛐蛐2 2019-11-20 00:00:00 发表: under review, beContent=蛐蛐2 2019-11-20 00:00:00 发表: under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/07/daf9b2a0c54c44f56adacf00fe8c4244.jpg, createdBy=356a5091985, createdName=13045d5bb3m, createdTime=Thu Nov 21 00:00:00 CST 2019, time=2019-11-21, status=1, ipAttribution=)]

2021-06-22 1470fb34m70(暂无昵称)

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：血液病
经验分享：一个月给了意见，给了3个月，修回接受

200 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=800300, encodeId=0bef80030014, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：大概4个月就接受了小修了1次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MX6tU5ibUmUNUc3QuraXVibmr9eSic7DuT3y7gKap2C8NQl1DicYOy0tgTHxNNZbNHfXwyvhWdt2CUhiaicYHHEggDUg/132, createdBy=2ede2416652, createdName=Cynthia开心, createdTime=Mon Jun 29 18:43:35 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574755, encodeId=e42c5e47558e, content=三个月了，一审还在under review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eunqL11r55A8WAWlyWs0EnafPqUs8awD2Jsk71ggkmlWicOGpfTScjbNxecDibU9J2TQjcVafFgY0hju6sfJS9rQ/132, createdBy=c6852367423, createdName=122e6881m72暂无昵称, createdTime=Tue Aug 13 21:09:00 CST 2019, time=2019-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170187, encodeId=a58f21e0187a5, content=作者登录页面是换吗，怎么点击submit 后，变成需要重新注册了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f108140910, createdName=ms5000001791427926, createdTime=Wed Nov 22 10:32:05 CST 2023, time=2023-11-22, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2157610, encodeId=45f2215e610ff, content=审稿速度:1.0 偏重的研究方向：hematology 经验分享：under review 状态一般持续多久呀？临床型的文章更容易中吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Thu Sep 14 00:23:58 CST 2023, time=2023-09-14, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=977647, encodeId=287b9e7647f7, content=请问接受个案吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ca9f5408920, createdName=ms1000000940702777, createdTime=Mon Jun 28 17:54:44 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975847, encodeId=08639e58478e, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：血液病 经验分享：一个月给了意见，给了3个月，修回接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a1f5188251, createdName=1470fb34m70(暂无昵称), createdTime=Tue Jun 22 16:57:26 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187968, encodeId=7c5b118e9686f, content=偏重的研究方向：白血病 经验分享：2022年1月23投，现在还是submit to Journal，求问这个状态啥时候才会提交给编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd785646397, createdName=ms4000000531946229, createdTime=Tue Jan 25 10:50:34 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086716, encodeId=a6d51086e16f6, content=每个期刊梯度一般情况下选择几个备选期刊合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086715, encodeId=8d891086e153e, content=选刊时需要从高到低设置期刊梯度吗？一般设置几个梯度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580213, encodeId=d0d9580213e2, content=啊，难道4个月了，还没送外审蛐蛐2 2019-11-20 00:00:00 发表: under review, beContent=蛐蛐2 2019-11-20 00:00:00 发表: under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/07/daf9b2a0c54c44f56adacf00fe8c4244.jpg, createdBy=356a5091985, createdName=13045d5bb3m, createdTime=Thu Nov 21 00:00:00 CST 2019, time=2019-11-21, status=1, ipAttribution=)]

2022-01-25 ms4000000531946229

偏重的研究方向：白血病
经验分享：2022年1月23投，现在还是submit to Journal，求问这个状态啥时候才会提交给编辑

159 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=800300, encodeId=0bef80030014, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：大概4个月就接受了小修了1次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MX6tU5ibUmUNUc3QuraXVibmr9eSic7DuT3y7gKap2C8NQl1DicYOy0tgTHxNNZbNHfXwyvhWdt2CUhiaicYHHEggDUg/132, createdBy=2ede2416652, createdName=Cynthia开心, createdTime=Mon Jun 29 18:43:35 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574755, encodeId=e42c5e47558e, content=三个月了，一审还在under review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eunqL11r55A8WAWlyWs0EnafPqUs8awD2Jsk71ggkmlWicOGpfTScjbNxecDibU9J2TQjcVafFgY0hju6sfJS9rQ/132, createdBy=c6852367423, createdName=122e6881m72暂无昵称, createdTime=Tue Aug 13 21:09:00 CST 2019, time=2019-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170187, encodeId=a58f21e0187a5, content=作者登录页面是换吗，怎么点击submit 后，变成需要重新注册了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f108140910, createdName=ms5000001791427926, createdTime=Wed Nov 22 10:32:05 CST 2023, time=2023-11-22, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2157610, encodeId=45f2215e610ff, content=审稿速度:1.0 偏重的研究方向：hematology 经验分享：under review 状态一般持续多久呀？临床型的文章更容易中吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Thu Sep 14 00:23:58 CST 2023, time=2023-09-14, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=977647, encodeId=287b9e7647f7, content=请问接受个案吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ca9f5408920, createdName=ms1000000940702777, createdTime=Mon Jun 28 17:54:44 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975847, encodeId=08639e58478e, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：血液病 经验分享：一个月给了意见，给了3个月，修回接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a1f5188251, createdName=1470fb34m70(暂无昵称), createdTime=Tue Jun 22 16:57:26 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187968, encodeId=7c5b118e9686f, content=偏重的研究方向：白血病 经验分享：2022年1月23投，现在还是submit to Journal，求问这个状态啥时候才会提交给编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd785646397, createdName=ms4000000531946229, createdTime=Tue Jan 25 10:50:34 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086716, encodeId=a6d51086e16f6, content=每个期刊梯度一般情况下选择几个备选期刊合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086715, encodeId=8d891086e153e, content=选刊时需要从高到低设置期刊梯度吗？一般设置几个梯度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580213, encodeId=d0d9580213e2, content=啊，难道4个月了，还没送外审蛐蛐2 2019-11-20 00:00:00 发表: under review, beContent=蛐蛐2 2019-11-20 00:00:00 发表: under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/07/daf9b2a0c54c44f56adacf00fe8c4244.jpg, createdBy=356a5091985, createdName=13045d5bb3m, createdTime=Thu Nov 21 00:00:00 CST 2019, time=2019-11-21, status=1, ipAttribution=)]

2021-12-27 MS54455111222

每个期刊梯度一般情况下选择几个备选期刊合适？

175 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=800300, encodeId=0bef80030014, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：大概4个月就接受了小修了1次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MX6tU5ibUmUNUc3QuraXVibmr9eSic7DuT3y7gKap2C8NQl1DicYOy0tgTHxNNZbNHfXwyvhWdt2CUhiaicYHHEggDUg/132, createdBy=2ede2416652, createdName=Cynthia开心, createdTime=Mon Jun 29 18:43:35 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574755, encodeId=e42c5e47558e, content=三个月了，一审还在under review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eunqL11r55A8WAWlyWs0EnafPqUs8awD2Jsk71ggkmlWicOGpfTScjbNxecDibU9J2TQjcVafFgY0hju6sfJS9rQ/132, createdBy=c6852367423, createdName=122e6881m72暂无昵称, createdTime=Tue Aug 13 21:09:00 CST 2019, time=2019-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170187, encodeId=a58f21e0187a5, content=作者登录页面是换吗，怎么点击submit 后，变成需要重新注册了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f108140910, createdName=ms5000001791427926, createdTime=Wed Nov 22 10:32:05 CST 2023, time=2023-11-22, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2157610, encodeId=45f2215e610ff, content=审稿速度:1.0 偏重的研究方向：hematology 经验分享：under review 状态一般持续多久呀？临床型的文章更容易中吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Thu Sep 14 00:23:58 CST 2023, time=2023-09-14, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=977647, encodeId=287b9e7647f7, content=请问接受个案吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ca9f5408920, createdName=ms1000000940702777, createdTime=Mon Jun 28 17:54:44 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975847, encodeId=08639e58478e, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：血液病 经验分享：一个月给了意见，给了3个月，修回接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a1f5188251, createdName=1470fb34m70(暂无昵称), createdTime=Tue Jun 22 16:57:26 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187968, encodeId=7c5b118e9686f, content=偏重的研究方向：白血病 经验分享：2022年1月23投，现在还是submit to Journal，求问这个状态啥时候才会提交给编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd785646397, createdName=ms4000000531946229, createdTime=Tue Jan 25 10:50:34 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086716, encodeId=a6d51086e16f6, content=每个期刊梯度一般情况下选择几个备选期刊合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086715, encodeId=8d891086e153e, content=选刊时需要从高到低设置期刊梯度吗？一般设置几个梯度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580213, encodeId=d0d9580213e2, content=啊，难道4个月了，还没送外审蛐蛐2 2019-11-20 00:00:00 发表: under review, beContent=蛐蛐2 2019-11-20 00:00:00 发表: under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/07/daf9b2a0c54c44f56adacf00fe8c4244.jpg, createdBy=356a5091985, createdName=13045d5bb3m, createdTime=Thu Nov 21 00:00:00 CST 2019, time=2019-11-21, status=1, ipAttribution=)]

2021-12-28 学医的彭于晏

选刊时需要从高到低设置期刊梯度吗？一般设置几个梯度？

177 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=800300, encodeId=0bef80030014, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：大概4个月就接受了小修了1次, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MX6tU5ibUmUNUc3QuraXVibmr9eSic7DuT3y7gKap2C8NQl1DicYOy0tgTHxNNZbNHfXwyvhWdt2CUhiaicYHHEggDUg/132, createdBy=2ede2416652, createdName=Cynthia开心, createdTime=Mon Jun 29 18:43:35 CST 2020, time=2020-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574755, encodeId=e42c5e47558e, content=三个月了，一审还在under review。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/eunqL11r55A8WAWlyWs0EnafPqUs8awD2Jsk71ggkmlWicOGpfTScjbNxecDibU9J2TQjcVafFgY0hju6sfJS9rQ/132, createdBy=c6852367423, createdName=122e6881m72暂无昵称, createdTime=Tue Aug 13 21:09:00 CST 2019, time=2019-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170187, encodeId=a58f21e0187a5, content=作者登录页面是换吗，怎么点击submit 后，变成需要重新注册了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f108140910, createdName=ms5000001791427926, createdTime=Wed Nov 22 10:32:05 CST 2023, time=2023-11-22, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2157610, encodeId=45f2215e610ff, content=审稿速度:1.0 偏重的研究方向：hematology 经验分享：under review 状态一般持续多久呀？临床型的文章更容易中吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Thu Sep 14 00:23:58 CST 2023, time=2023-09-14, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=977647, encodeId=287b9e7647f7, content=请问接受个案吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=223, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ca9f5408920, createdName=ms1000000940702777, createdTime=Mon Jun 28 17:54:44 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975847, encodeId=08639e58478e, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：血液病 经验分享：一个月给了意见，给了3个月，修回接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a1f5188251, createdName=1470fb34m70(暂无昵称), createdTime=Tue Jun 22 16:57:26 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187968, encodeId=7c5b118e9686f, content=偏重的研究方向：白血病 经验分享：2022年1月23投，现在还是submit to Journal，求问这个状态啥时候才会提交给编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd785646397, createdName=ms4000000531946229, createdTime=Tue Jan 25 10:50:34 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086716, encodeId=a6d51086e16f6, content=每个期刊梯度一般情况下选择几个备选期刊合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086715, encodeId=8d891086e153e, content=选刊时需要从高到低设置期刊梯度吗？一般设置几个梯度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=580213, encodeId=d0d9580213e2, content=啊，难道4个月了，还没送外审蛐蛐2 2019-11-20 00:00:00 发表: under review, beContent=蛐蛐2 2019-11-20 00:00:00 发表: under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/07/daf9b2a0c54c44f56adacf00fe8c4244.jpg, createdBy=356a5091985, createdName=13045d5bb3m, createdTime=Thu Nov 21 00:00:00 CST 2019, time=2019-11-21, status=1, ipAttribution=)]

2019-11-21 13045d5bb3m

啊，难道4个月了，还没送外审蛐蛐2 2019-11-20 00:00:00 发表:
under review

蛐蛐2 2019-11-20 00:00:00 发表: under review

196 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务